13F Holdings
中文EN

BGMS Bio Green Med Solution, Inc.

Wholesale-Durable Goods, NEC · Nasdaq · SEC CIK 1130166 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY69.4%
TTM EPS YoY75.3%
Revenue 3-yr CAGR55.1%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-156.1%
Net margin-114.5%
FCF margin—
EBITDA margin-155.7%

Returns

ROE-24.2%
ROA-21.3%
ROIC (approx.)-68.7%
Asset turnover0.19x

Leverage & solvency

Liabilities / assets10.9%
Debt / equity0.00x
Current ratio6.84x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.57x
Accruals ratio-9.1%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$0$43,000$420,000$0$0
R&D expense$848,000$6.66M$19.16M$20.27M$14.93M
SG&A expense$7.72M$5.39M$6.72M$7.38M$7.46M
Operating income-$8.43M-$12.00M-$25.45M-$27.66M-$22.39M
Pretax income-$2.99M-$11.99M-$25.55M-$25.91M-$22.18M
Income tax$7,000-$782,000-$3.00M-$4.72M-$3.73M
Net income-$3.00M-$11.21M-$22.55M-$21.20M-$18.46M
EBITDA-$8.42M-$12.00M-$25.42M-$27.62M-$22.35M
EPS (basic)-6.45-502.46-6,419.18-1.90-2.09
EPS (diluted)-6.45-502.46-6,419.18-27.24-2.09
Weighted avg. shares (diluted)2.19M22,3143.54M11.26M8.93M
Banking
Net interest income$62,000$12,000———
Balance sheet
Cash & equivalents$3.50M$3.14M$3.38M$18.34M$36.56M
Short-term investments———$4.55M$4.48M
Receivables$1.26M————
Inventory$1.38M————
Current assets$6.26M$3.67M$7.44M$24.41M$40.94M
PP&E, net$137,000$3,000$9,000$32,000$64,000
Goodwill$1.57M————
Total assets$8.19M$4.09M$8.80M$28.05M$43.14M
Current liabilities$1.33M$6.27M$8.16M$7.51M$5.41M
Total liabilities$1.34M$6.27M$8.20M$7.62M$5.44M
Shareholders' equity$6.84M-$2.17M$607,000$15.94M$37.69M
Shares outstanding5.40M36,9134,412628,1399.99M
Cash flow statement
Operating cash flow-$4.77M-$7.99M-$16.11M-$20.83M-$18.54M
Capital expenditure——$6,000$7,000$27,000
Free cash flow——-$16.12M-$20.83M-$18.57M
Investing cash flow——-$6,000-$7,000-$27,000
Financing cash flow$5.26M$7.82M$848,000$3.00M$21.74M
Depreciation & amortization$5,000$6,000$31,000$32,000$43,000
Stock-based compensation$2.33M$592,000$1.47M$1.51M$1.16M

Free plan shows the latest 5 periods; Pro shows all 28 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.